Fundraising Fox

Elemind

Founded 2019 · 12 employees on LinkedIn · 7 known investors

Find your way into Elemind

183 people in our graph share verified history with the Elemind team — schools, employers, funds. One of them is your warm intro.

Dr. Catherine Havasiunlockedknows Heather Read · together at MIT Media Lab (overlapped)
×6knows the team · via MIT Media Lab
×3knows the team · via The Rockefeller University
×2knows the team · via Loyola University Chicago Stritch School of Medicine

Elemind makes a wearable neurotech sleep headband that measures EEG brain signals and delivers phase-locked acoustic stimulation to help users fall asleep faster and return to sleep after waking. The device pairs with a companion app for headband control and sleep tracking, and is sold to consumers with sleep difficulties.

Also known as Elemind Technologies · Elemind Technology

Founders & leadership

Elemind was founded in 2019 by David Wang, Meredith Perry, Ed Boyden, Nir Grossman, and Heather Read.

DWDavid Wang
David WanginCo-Founder + CTO
MPMeredith Perry
Meredith PerryinCo-Founder + CEO
EBEd Boyden
Ed BoydeninCo-Founder
NG
Nir GrossmanCo-Founder
HRHeather Read
Heather ReadinCo-Founder + Science AdvisorDr. Heather Read is a Professor of Psychological Sciences and Biomedical Engineering at the University of Connecticut who conducted research in neural encoding, brain mapping, and signal processing. She co-founded Elemind Technologies with colleagues from MIT, where she serves as Science Advisor, developing neurotechnology that uses phase-locked acoustic stimulation to modulate brain activity.
RRRoshan Rajappa
Roshan RajappainCOO

Investors · 7

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeed Funding RoundFeb 2024
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

Elemind is a neurotechnology company that develops and sells a wearable sleep headband. The device measures EEG brain signals and delivers acoustic stimulation timed to the wearer's own neural rhythms, with the stated aim of moving the brain out of wakeful patterns and into sleep on demand. The company positions the product as a drug-free alternative to sleep medication, intended both for initial sleep onset and for returning to sleep after a night-time awakening, which the user can trigger via a button on the headset.

Alongside the hardware, Elemind offers software features including an "AI Sleep Tailor" that learns from a user's sleep patterns and self-reported feedback to generate stimulation patterns over time, and sleep analytics that the company differentiates from passive sleep tracking. The company describes the product as backed by five years of research, testing and clinical trials, and cites a clinical study in which 76% of participants fell asleep significantly faster and in which sleep efficiency improved.

Business model

Direct-to-consumer sale of a wearable hardware device with an accompanying app; the headband is listed at $399 with a 30-day money-back guarantee (less shipping and handling) and is stated to be HSA/FSA eligible.

Product revenue from consumer hardware sales, sold at $399 per headband through the company's online store.

Traction

The company reports clinical study results in which 76% of participants fell asleep significantly faster, five years of research and clinical testing, and states that thousands of users fall asleep faster with the product; the website features verified-buyer reviews and consumer press mentions.

Full profile — market position, technology, go-to-market

Market position

Consumer neurotechnology/sleep-wearable vendor, framing itself as a category leader in real-time brainwave modulation for sleep.

Positions itself against passive sleep trackers and pharmaceutical sleep aids by actively intervening in brain activity in real time rather than only measuring sleep, and claims comparable effectiveness to leading sleep drugs without drug side effects.

Technology

Real-time EEG measurement combined with phase-targeted acoustic neuromodulation: the headband reads brain signals and delivers acoustic stimulation tailored to the individual's natural brainwave rhythms. An AI component ("AI Sleep Tailor") adapts stimulation patterns based on recorded sleep data and user feedback. The company claims to be the first to modulate brainwaves in real time.

Go-to-market

Online direct sales through the company's own store, supported by consumer press coverage (including Mashable and the New York Post) and customer reviews, plus HSA/FSA payment eligibility.

Consumers with difficulty falling asleep or returning to sleep, including people describing chronic insomnia, night-shift workers, and parents of young children.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Product priceJan 2025$399
Study participants falling asleep significantly fasterJan 202576%
Years of research, testing and clinical trialsJan 20255 years

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Elemind do?
Elemind sells a $399 wearable headband that reads EEG brainwaves and delivers acoustic stimulation to help users fall asleep faster.
Who founded Elemind?
Elemind was founded by David Wang, Meredith Perry, Ed Boyden, Nir Grossman, Heather Read in 2019.
Who are Elemind's investors?
Elemind's investors include Evolution VC Partners, Green Meadow Ventures, Joyance Partners, Metaplanet, Modi Ventures, The E14 Fund, The Family Fund.